{"document": {"publication": "Tag My News", "full_text": "taking the novartis cancer drug gleevec for three years following surgery to remove gastrointestinal stromal tumors (gist) extended survival in more high-risk patients than the standard one year of gleevec treatment, according to data released on sunday.", "title": "longer gleevec use extends gist patient survival", "line_count": 1, "filename": "20895", "publication_date": "05-06-2011 15:27:46", "lines_and_colors": [["taking the novartis cancer drug gleevec for three years following surgery to remove gastrointestinal stromal tumors (gist) extended survival in more high-risk patients than the standard one year of gleevec treatment, according to data released on sunday.", {}]]}}